Farmaceutica

/Farmaceutica

01-2019 – Quali Regole per la Spesa Farmaceutica? Criticità, Impatti, Proposte

Con questo paper Fondazione CERM raccoglie le prospettive e le analisi di un gruppo di ricerca in cui sono confluite sensibilità e competenze diverse e complementari, con l’obiettivo di contribuire al dibattito sul governo della spesa farmaceutica e sulla regolazione del settore. Le analisi e le proposte che qui presentiamo saranno offerte anche alla discussione in una serie di seminari dedicati, per raccogliere contributi specifici e prospettive capaci di stimolare integrazioni e revisioni rispetto al quadro che, sin qui, [...]

Autore : |2020-02-05T07:22:33+00:0025 Novembre 2019|Categories: Farmaceutica, Working Papers|Tags: , |

N. 06-2014 – Structure and Evolution of the Bio-Pharmaceutical Patent Network

Recent work in the study of multiple networks has provided new insights into the dynamics of competition between complex systems [1] and the importance of individual nodes [2,3] in each sub-network. To study the importance of a National Innovation System in the global economy, we represent the global patent citation network as a multiplexed network of individual national economies, and model the technological spillovers due to innovation originating in a specific national economy as a random walk between patent [...]

Autore : |2020-01-21T12:13:15+00:0023 Maggio 2014|Categories: Farmaceutica, Working Papers, Working Papers SWITCH|Tags: |

N. 05-2014 – The role of the pharmaceutical industry in the global input-output system

We refer to input-output analysis to investigate the global trade system and to assess the impact of the pharmaceutical industry on the world economy. Our central findings can be summarized as follows: Overall, the global input-output system has become more integrated over time; The pharmaceutical industry has become more globalized over time; The impact of the pharmaceutical industry, measured by the Leontief multipliers, is persistently high and stable in EU15, whereas it has been slightly decreasing in the US; China [...]

Autore : |2020-01-21T16:47:26+00:0023 Maggio 2014|Categories: Farmaceutica, Working Papers, Working Papers SWITCH|Tags: , |

N. 04-2014 – Mobility of Inventors in the Bio-pharmaceutical Industry

Network science provides a variety of methods to better understand the complex growth trends underlying the development of the European Research Area (ERA), the EU vision to develop a homogenized innovation system that is more efficient and competitive than a collection of national innovation systems. As a collection of member states, with a rich political history, it goes without saying that the history of the EU is inextricably embedded in cultural, language, and political borders, which in some cases are [...]

Autore : |2020-01-21T16:47:34+00:0023 Maggio 2014|Categories: Farmaceutica, Working Papers, Working Papers SWITCH|Tags: , , |

N. 03-2014 – Biomedical Innovation Clusters

Tracking the street level location of biomedical publications, we reveal clusters of innovative activity within cities. Using the keywords describing the content of the publications we can further track the geographic flow of new ideas, and in turn, devise a measure of innovation capabilities in the biomedical sciences and in bio-pharmaceuticals. The geography of innovative output is established in two steps. First, clusters are aggregated by connecting all loci of production less than 1km apart. Once these connections have been [...]

Autore : |2020-01-21T16:47:43+00:0023 Maggio 2014|Categories: Farmaceutica, Working Papers, Working Papers SWITCH|Tags: , |

N. 02-2014 – A birds-eye view of SWITCH big data project

SWITCH relies on a wide range of datasets, which can be used to quantitatively understand innovation and competition in pharmaceuticals, and to describe the impact of geographic, technological, institutional, and temporal differences on a variety of processes and domains of investigation. Main sources of data: Patents: Multiple databases provide information about patent applications and publications, with different information contained in each list. Many include technological classifications and citations [dataverse, oecd, orbis], with high-resolution geographic information available for applicants [oecd] of [...]

Autore : |2020-01-21T16:47:49+00:0023 Maggio 2014|Categories: Farmaceutica, Working Papers, Working Papers SWITCH|Tags: , |

The Switch Project Latest Publications

The Switch Project Team has posted new items: A birds-eye view of SWITCH big data project, by Greg Morrison Demographic uncertainty, the financing mix and the sustainability of welfare system, by Luca Regis Biomedical Innovation Clusters, by Orion Penner and Massimo Riccaboni Mobility of Inventors in the Bio-pharmaceutical Industry, by Alexander Petersen The role of the pharmaceutical industry in the global input-output system, by Zhen Zhu Structure and Evolution of the Bio-Pharmaceutical Patent Network, by Greg Morrison SCARICA IL PDF [...]

N. 01-2014 – Demographic uncertainty, the financing mix and the sustainability of welfare systems

Demographic changes are threatening the sustainability of welfare expenditure in all Western countries. Two clear trends have characterized the last decades, and are expected to affect future population dynamics: Constantly improving longevity; Decreasing fertility. The combined effect of these two phenomena have caused a fast and dramatic change in the structure of populations. Children below age 5, which constituted the larger age class in 1960, will very soon be outnumbered by people older than 80 years. Old-age dependency ratios, which [...]

Autore : |2020-01-21T16:48:08+00:0023 Maggio 2014|Categories: Farmaceutica, Working Papers, Working Papers SWITCH|Tags: , |

01-2014 – Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell’Italia nel contesto europeo

Questa Nota è un insieme articolato di evidenze empiriche sull’evoluzione del mercato dei prodotti farmaceutici a brevetto scaduto (off patent) in Europa, con un focus sull’Italia. Lo studio esamina il mercato off patent nel suo complesso, prendendo in considerazione gli andamenti in prezzi e volumi di tutti i prodotti interessati dalla scadenza brevettuale. Dopo aver evidenziato le principali differenze tra Paesi in termini di composizione complessiva del mercato, lo studio si concentra sulla descrizione degli effetti della scadenza del [...]

Autore : |2020-01-21T11:19:54+00:0024 Marzo 2014|Categories: Farmaceutica, Working Papers|Tags: , |

02-2012 – I Farmaci Oncologici in Italia: Innovazione e sostenibilità economica

I farmaci innovativi ad alto costo ci fanno toccare con mano quali potranno essere i dilemmi della sanità futura se non si completano le riforme della governance di questo capitolo complesso della spesa pubblica (non solo federalismo, ma sistemi contabili e di reporting, schemi di compartecipazione al costo, screening delle prassi terapeutiche per sollecitare best practice, etc.). Quel trade-off crudo che abbiam di fronte, tra sostenibilità della spesa e domanda di prestazioni da parte dei cittadini, è, per i farmaci [...]

Autore : |2020-01-21T11:20:48+00:0026 Giugno 2012|Categories: Farmaceutica, Innovazione e produttività, Working Papers|Tags: , |